Although CD137 (4-1BB) activates CAR-T cells and increases their proliferation and persistence, further exploration of the pathway that regulates metabolism and differentiation of T cells on these activating receptors will undoubtedly increase the accuracy and specificity of clinical applications for different types of hematological malignancies. The gene discussed is TNFRSF9; the disease is hematologic disorder.